By Mars Woo
Gaocheng Capital was founded by Jing Hong, a former partner at Hillhouse Capital.
It did not specify how the 15 percent stake was divided up between the six firms but added that the deal could eventually aid plans for CRSCS to go public.
Sciwind Biosciences is a drug research and development company targeting metabolic diseases.
Despite the cutbacks, Didi intends to add 2,500 people to focus on areas from its international expansion to safety and product engineering.
Alibaba’s interest comes after rival Tencent last year signed a partnership deal with France’s Carrefour.
Shiji had in early 2018 secured an investment of $486 million from Chinese internet giant Alibaba in exchange for a 38% stake in a subsidiary.
The value of the deal was not disclosed but Japanese financial research provider DZH Financial Research said it is close to $162.2 million.
Bilibili is one of China’s leading online video sharing and entertainment platforms and was listed on Nasdaq in March 2018.
The deal marks Ant’s biggest overseas deal since its bid to acquire US-based MoneyGram was thwarted last year.
BNP Paribas has hired Paul Sandhu as head of multi-assets quant solutions and client advisory for Asia Pacific.